Status:
COMPLETED
The Effect of Sugammadex During Transcranial Electrical Motor Evoked Potential Monitoring in Spinal Surgery
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
Sugammadex
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Transcranial motor evoked potential (TcMEP) monitoring is conventionally performed during neurosurgical procedures without or with minimal neuromuscular blockade (NMB) because of its potential interfe...
Eligibility Criteria
Inclusion
- 18-65 years
- ASA status I-II
- Patients undergo thoracic or lumbar spinal surgery
- tcMEP monitoring during the surgery
- Informed consent signed by patients
Exclusion
- BMI ≥35 Kg/m-2
- history of epilepsy or use of antiepileptic drugs, neuromuscular disorder(s)
- history or family history of malignant hyperthermia
- allergies to sugammadex, NMBs or other medication(s) used during general anesthesia
- anemia, hemoglobin \<110g/L,
- TcMEPs stimulate or record site infection
- preoperative neurological dysfunction in both upper extremities
- cardiac pacemaker
- pregnancy and breast-feeding
Key Trial Info
Start Date :
July 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04471376
Start Date
July 16 2020
End Date
December 31 2020
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, China, 100070